Qu, Yongming
Eli Lilly (United States)
4 papers on CoChatORCID 0000-0003-3643-8066
Most cited papers
- Verified
Effects of Exenatide Combined with Lifestyle Modification in Patients with Type 2 Diabetes
Apovian, C. M., Bergenstal, R. M., Cuddihy, R. M., Qu, Y., Lenox, S., Lewis, M. S., & Glass, L. C. (2010) · The American Journal of Medicine
Diabetes Treatment and ManagementPharmacology and Obesity Treatment
Cited by 127
- Verified
Rate of hypoglycemia in insulin-treated patients with type 2 diabetes can be predicted from glycemic variability data
Qu, Y., Jacober, S. J., Zhang, Q., Wolka, L. L., & DeVries, J. H. (2012) · Diabetes Technology & Therapeutics
Diabetes Management and ResearchDiabetes Treatment and Management
Cited by 126
- Verified
Effects of Exenatide Plus Rosiglitazone on β-Cell Function and Insulin Sensitivity in Subjects With Type 2 Diabetes on Metformin
DeFronzo, R. A., Triplitt, C., Qu, Y., Lewis, M. S., Maggs, D., & Glass, L. C. (2010) · Diabetes Care
Diabetes Treatment and ManagementPancreatic function and diabetes
Cited by 104
- Verified
Better Glycemic Control and Weight Loss With the Novel Long-Acting Basal Insulin LY2605541 Compared With Insulin Glargine in Type 1 Diabetes
Rosenstock, J., Bergenstal, R. M., Blevins, T. C., Morrow, L. A., Prince, M. J., Qu, Y., Sinha, V. P., Howey, D. C., & Jacober, S. J. (2013) · Diabetes Care
Diabetes Management and ResearchDiabetes Treatment and Management
Cited by 96
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free